Literature DB >> 9688848

Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin.

C Jiang1, S L Fang, Y F Xiao, S P O'Connor, S G Nadler, D W Lee, D M Jefferson, J M Kaplan, A E Smith, S H Cheng.   

Abstract

Deletion of the codon encoding phenylalanine 508 (DeltaF508) is the most common mutation in cystic fibrosis (CF) and results in a trafficking defect. Mutant DeltaF508-CF transmembrane conductance regulator (CFTR) protein retains functional activity, but the nascent protein is recognized as abnormal and, in consequence, is retained in the endoplasmic reticulum (ER) and degraded. It has been proposed that this retention in the ER is mediated, at least in part, by the cellular chaperones heat shock protein (HSP) 70 and calnexin. We have investigated the ability of deoxyspergualin (DSG), a compound known to compete effectively for binding with HSP70 and HSP90, to promote trafficking of DeltaF508-CFTR to the cell membrane. We show that DSG treatment of immortalized human CF epithelial cells (DeltaF508) and cells expressing recombinant DeltaF508-CFTR partially restored cAMP-stimulated CFTR Cl- channel activity at the plasma membrane. Although there are several possible explanations for these results, one simple interpretation is that DSG may have altered the interaction between DeltaF508-CFTR and its associated chaperones. If this is correct, agents capable of altering the normal functioning of cellular chaperones may provide yet another means of restoring CFTR Cl- channel activity to CF subjects harboring this class of mutations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688848     DOI: 10.1152/ajpcell.1998.275.1.C171

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

Review 1.  Novel pharmacologic therapies for cystic fibrosis.

Authors:  P L Zeitlin
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 2.  Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.

Authors:  J R Riordan
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

Review 3.  Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.

Authors:  Marina S Gelman; Ron R Kopito
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast.

Authors:  Y Zhang; G Nijbroek; M L Sullivan; A A McCracken; S C Watkins; S Michaelis; J L Brodsky
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

5.  4-Phenylbutyrate stimulates Hsp70 expression through the Elp2 component of elongator and STAT-3 in cystic fibrosis epithelial cells.

Authors:  Laurence Suaud; Katelyn Miller; Ashley E Panichelli; Rachel L Randell; Catherine M Marando; Ronald C Rubenstein
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

6.  Endoplasmic reticulum protein quality control is determined by cooperative interactions between Hsp/c70 protein and the CHIP E3 ligase.

Authors:  Yoshihiro Matsumura; Juro Sakai; William R Skach
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 7.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

8.  Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.

Authors:  Baoxue Yang; Dan Zhao; A S Verkman
Journal:  FASEB J       Date:  2008-10-14       Impact factor: 5.191

9.  Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking.

Authors:  Xiaodong Wang; Atanas V Koulov; Wendy A Kellner; John R Riordan; William E Balch
Journal:  Traffic       Date:  2008-07-30       Impact factor: 6.215

10.  A soluble sulfogalactosyl ceramide mimic promotes Delta F508 CFTR escape from endoplasmic reticulum associated degradation.

Authors:  Hyun-Joo Park; Murugesapillai Mylvaganum; Anne McPherson; Sheara W Fewell; Jeffrey L Brodsky; Clifford A Lingwood
Journal:  Chem Biol       Date:  2009-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.